Bladder cancer chemotherapy comes home: new trial tests convenience and safety

NCT ID NCT06704191

Recruiting now Symptom relief Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving chemotherapy directly into the bladder at home is safe and acceptable for people with non-muscle invasive bladder cancer. About 40 participants will receive their usual medications—such as BCG, gemcitabine, docetaxel, or mitomycin—at home instead of in a clinic. The goal is to see if home treatment reduces disruption to daily life while remaining safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BCG solution, docetaxel, gemcitabine, mitomycin
What this could lead to: If successful, this could make bladder cancer treatment more convenient by allowing patients to receive therapy at home instead of traveling to a clinic.
What could go wrong: This is an early-phase trial with only 40 participants, so results may not apply to everyone. Home treatment may have safety risks or be less acceptable than expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bladder carcinoma in situ non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-MUSCLE INVASIVE BLADDER CARCINOMA STAGE 0A BLADDER CANCER AJCC V8 STAGE 0IS BLADDER CANCER AJCC V8 STAGE I BLADDER CANCER AJCC V8

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Mayo Clinic in Florida
RECRUITING

Jacksonville, Florida, 32224-9980, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.